NoticeThis is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
"Ph1:
•Locally advanced (LA) or metastatic MTAP-deleted (met.MTAP-del.) solid tumors
•MTAP-del.relapsed or refrac. Grade 4 astrocytoma or glioblastoma multiforme (R/R GBM)
Ph2:
A1:LA or met.MTAP-del. squamous and nonsquamous NSCLC
A2:LA or met.MTAP-del. mesothelioma
A3:LA or met.MTAP-del. sarcoma
A4:LA or met.MTAP-del. pancreatic ductal adenocarcinoma or adenosquamous carcinoma w/predominantly adenocarcinoma histology
A5:Other LA or met.MTAP-del. solid tumors
A6:MTAP-del. R/R GBM"
1 total trials
Filter these 1 trials by phase, country, sponsor and more.